Union Budget 2026: BioPharma Shakti and the Strategic Shift in Indian Healthcare
Frequently Asked Questions
BioPharma Shakti is a national program with an outlay of Rs 10,000 crore over five years, aimed at making India a global hub for biologics and biosimilars manufacturing.
The government announced full basic customs duty exemptions on 17 critical cancer medicines and expanded duty-free personal imports for seven additional rare diseases.
NIMHANS 2.0 will be established in North India, with regional hubs for mental health treatment and research also planned for Ranchi and Tezpur.
The budget aims to train 1.5 lakh multi-skilled caregivers in the next year and add 1 lakh Allied Health Professionals over the next five years.
The budget proposes five regional medical tourism hubs that integrate modern clinical care with AYUSH treatments and advanced rehabilitation services.
Did your stocks survive the war?
See what broke. See what stood.
Live Q4 Earnings Tracker
